Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €7.16 EUR
Change Today +0.418 / 6.20%
Volume 2.5K
APS On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 3:08 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Frank G. Haluska M.D., Ph.D.

Chief Medical Officer and Senior Vice President of Clinical Research & Development,Ariad Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

56--

Background*

Dr. Frank G. Haluska, M.D. Ph.D. has been Chief Medical Officer at Ariad Pharmaceuticals Inc., since June 2010 and has been its Senior Vice President of Clinical R&D since January 2012. Dr. Haluska served as Vice President of Clinical Research and Development at Ariad Pharmaceuticals Inc. since June 2010. He served as Senior Medical Director of Ariad Pharmaceuticals Inc. since November 2007 until July 2010. He responsible for leading multiple clinical trials of oral ...

Read Full Background

Corporate Headquarters*

26 Landsdowne Street
Cambridge, Massachusetts 02139

United States

Phone: 617-494-0400
Fax: 617-494-8144

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Harvard University
Master's Degree
Massachusetts Institute of Technology
PhD
University of Pennsylvania - School of Medicine
MD
University of Pennsylvania - School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APS:GR €7.16 EUR +0.418

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
$548.8K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$755.2K
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
€459.0K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$568.5K
Aijaz Tobaccowalla Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee
Pfizer Limited
52.4M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.